Effects of rosiglitazone on the configuration of action potentials and ion currents in canine ventricular cells

Thiazolidinedione Drugs and Cardiovascular Risks

(2010) Sanjay Kaul et al.   CIRCULATION

Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents

(2010) Lalit S Doshi et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications

(2009) Andrew Krentz   DIABETES-METABOLISM RESEARCH AND REVIEWS

Cardiac safety profile of rosiglitazone

(2009) Edoardo Mannucci et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Distinct modulation of voltage-gated and ligand-gated Ca2+currents by PPAR-γ agonists in cultured hippocampal neurons

(2009) Tristano Pancani et al.   JOURNAL OF NEUROCHEMISTRY

Peroxisome Proliferator-Activated Receptor   Antagonists Decrease Na+ Transport via the Epithelial Na+ Channel

(2009) T. S. Pavlov et al.   MOLECULAR PHARMACOLOGY

New Drugs for the Treatment of Diabetes Mellitus

(2008) Darren K. McGuire et al.   CIRCULATION

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

(2008)   DIABETES CARE

Thiazolidinedione drugs block cardiac KATP channels and may increase propensity for ischaemic ventricular fibrillation in pigs

(2008) L. Lu et al.   DIABETOLOGIA

Role of slow delayed rectifier K+-current in QT prolongation in the alloxan-induced diabetic rabbit heart

(2007) Cs. Lengyel et al.   Acta Physiologica

Thiazolidinediones: effects on insulin resistance and the cardiovascular system

(2007) C E Quinn et al.   BRITISH JOURNAL OF PHARMACOLOGY